Terns Pharmaceuticals, Inc. · NASDAQ:TERN
Morgan Stanley reported a 8.10% stake in Terns Pharmaceuticals, Inc. (Schedule 13G)
Event Mar 31, 2025 · Filed May 7, 2025
Morgan Stanley reported a 8.10% stake in Terns Pharmaceuticals, Inc., 7,099,954 shares, as a passive investor on Mar 31, 2025. Filed May 7, 2025 (Schedule 13G).
- Stake
- 8.10%
- Shares
- 7,099,954
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 8.10% | 7,099,954 |
| Morgan Stanley Capital Services LLC | 7.00% | 6,094,918 |
Source
Related
- Terns Pharmaceuticals, Inc.
- Morgan Stanley
- Terns Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · May 13, 2026
- Form 4 · Kuriakose Emil · May 5, 2026
- Form 4 · Gengos Andrew · May 5, 2026
- Form 4 · Burroughs Amy L. · May 5, 2026
- Form 4 · Kuriakose Emil · Apr 2, 2026